The mineralocorticoid receptor antagonist spironolactone enhances morphine antinociception

Abstract

Spironolactone has no antinociceptive effects in thermal models of pain, but it enhances the antinociceptive effects of morphine mainly by increasing morphine central nervous system concentrations, probably by inhibiting P-gp.